Robert L. Martuza

Affiliations: 
Massachusetts General Hospital, Boston, MA 
Google:
"Robert Martuza"
Mean distance: 18.87 (cluster 17)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang L, Ning J, Wakimoto H, et al. (2019) Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells. Molecular Therapy Oncolytics. 13: 58-66
Tanaka S, Luk S, Kiyokawa J, et al. (2019) Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy. Scientific Reports. 9: 139
Saha D, Martuza RL, Rabkin SD. (2018) Oncolytic herpes simplex virus immunovirotherapy in combination with immune checkpoint blockade to treat glioblastoma. Immunotherapy. 10: 779-786
Peters C, Paget M, Tshilenge KT, et al. (2018) RESTRICTION OF γ34.5-DELETED ONCOLYTIC HERPES SIMPLEX VIRUS REPLICATION IN GLIOBLASTOMA STEM-LIKE CELLS. Journal of Virology
Saha D, Wakimoto H, Peters CW, et al. (2018) Combinatorial effects of VEGFR kinase inhibitor axitinib and oncolytic virotherapy in mouse and human glioblastoma stem-like cell models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Saha D, Martuza RL, Rabkin SD. (2017) Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade. Oncoscience. 4: 67-69
Saha D, Martuza RL, Rabkin SD. (2017) Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade. Cancer Cell. 32: 253-267.e5
Esaki S, Nigim F, Moon E, et al. (2017) Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models. International Journal of Cancer
Ning J, Wakimoto H, Peters C, et al. (2017) Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma. Journal of the National Cancer Institute. 109: 1-13
Esaki S, Rabkin SD, Martuza RL, et al. (2016) Transient fasting enhances replication of oncolytic herpes simplex virus in glioblastoma. American Journal of Cancer Research. 6: 300-11
See more...